Compare Heron Therapeutics Inc (HRTX) vs Nasdaq100 ETF (QQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Nasdaq100 ETF — how do they compare? Heron Therapeutics Inc trades at $0.35 (market cap $61.47M), while Nasdaq100 ETF trades at $723.92. The key difference: Nasdaq100 ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | QQQ | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | — |
52-Week High | $1.49 | $746.16 |
52-Week Low | $0.32 | $558.34 |
Enterprise Value | $168.21M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
QQQ trades at $725.43, up 0.64% with a bullish technical signal from moving averages. The ETF shows strong institutional interest with Ferguson Shapiro LLC increasing its position by 2,685.7% according to SEC filings. Recent news highlights Nasdaq's tech-led rally potential in H2 2026, with momentum and Fed liquidity supporting further upside according to Zacks Investment Research.
Outlook remains positive given historical performance and current technical strength, though RSI levels suggest potential near-term consolidation. Key risks include ETF expense ratios and market volatility, while opportunities lie in continued tech sector leadership and institutional accumulation patterns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →
